Piclidenoson Completed Phase 2 Trials for Glaucoma / Ocular Hypertension Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01033422Safety and Efficacy of Daily CF101 Administered Orally in Subjects With Elevated Intraocular Pressure